Related Experiment Video
Updated: Oct 1, 2026

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP
Published on: October 17, 2015
Accumulation of the amyloid-beta precursor protein in multivesicular body-like organelles
Marcel M Verbeek1, Irene Otte-Höller, Jack A M Fransen
1Department of Neurology, University Medical Center Nijmegen, The Netherlands. m.verbeek@ckslkn.azn.nl
Abstract:
It has been suggested that the successive proteolytic events leading to the production of the amyloid-beta protein from its precursor may take place at different intracellular locations. Using cultured human leptomeningeal smooth muscle cells and brain pericytes, we modulated the intracellular localization of the amyloid-beta precursor protein (APP) to study possible effects on its processing. By using immunofluorescence and immunoelectron microscopy we demonstrated that, under normal conditions, the APP is found in small intracellular vesicles, some of which were characterized as lysosomes. Both the cytokine interferon-gamma and the lysosomotropic drug chloroquine, but not the cytokines interleukin (IL)-1, IL-6, or tumor necrosis factor-alpha (TNF-alpha), induced an accumulation of APP in newly formed multivesicular body-like organelles. The secretion of the amyloid-beta precursor protein was slightly reduced by interferon-gamma or chloroquine. Double-labeling and tracer molecule uptake experiments showed that the multivesicular body-like organelles were part of the endocytic pathway. Our findings suggest that the multivesicular body-like organelles function as an intermediate organelle in the intracellular trafficking of the APP. Accumulation of the APP in this organelle is reflected by its reduced secretion from the cell.
Insights
Interferon-gamma and chloroquine cause amyloid precursor protein (APP) to accumulate in cellular organelles, reducing its secretion. These findings highlight the role of multivesicular bodies in APP trafficking and processing.
Area of Science:
- Cell Biology
- Neuroscience
- Protein Biochemistry
Background:
- Amyloid-beta protein production involves proteolytic cleavage of its precursor (APP).
- The intracellular location of APP processing is not fully understood.
- APP processing may occur in different cellular compartments.
Purpose of the Study:
- To investigate the effect of modulating amyloid precursor protein (APP) localization on its processing.
- To identify the intracellular organelles involved in APP trafficking and amyloid-beta production.
Main Methods:
- Cultured human leptomeningeal smooth muscle cells and brain pericytes were used.
- Immunofluorescence and immunoelectron microscopy were employed to track APP localization.
- Interferon-gamma, chloroquine, IL-1, IL-6, and TNF-alpha were used to modulate APP processing.
Main Results:
- APP was found in intracellular vesicles, including lysosomes, under normal conditions.
- Interferon-gamma and chloroquine induced APP accumulation in multivesicular body-like organelles.
- These organelles were identified as part of the endocytic pathway.
- APP secretion was reduced by interferon-gamma or chloroquine.
Conclusions:
- Multivesicular body-like organelles serve as intermediate compartments for APP intracellular trafficking.
- APP accumulation in these organelles correlates with reduced secretion.
- This suggests a role for endocytic pathway organelles in regulating amyloid-beta precursor protein processing.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Intralumenal Vesicles and Multivesicular Bodies
Export of Misfolded Proteins out of the ER
Protein Folding Quality Check in the RER
Oligosaccharide Assembly
Multiple sugar molecules that may or may...

